Cogstate Ltd (COGZF) 0.7121 $COGZF Cogstate iPad

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2016 at 11:13 AM

Cogstate Ltd (COGZF) 0.7121 $COGZF

Cogstate iPad Cognitive Assessments Selected for Use in Phase IV Observational Study of Approved Treatments for Prostate Cancer
BusinessWire - Wed Nov 18, 7:00AM CST
Cogstate Ltd (ASX:CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Cogstate Releases Latest Version of Online Cognitive Screening Solution for Clinical Trials: Precision Recruitment
BusinessWire - Wed Jul 22, 8:00AM CDT
Cogstate Ltd (ASX:CGS), a cognitive science and medical technology company, today announced the latest version of its remote cognitive assessment solution for pre-screening participants in clinical trials, Precision Recruitment(TM) 2.1.

Leading 100 Medical Technology Companies of Asia 2015
M2 - Mon Mar 23, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3bxckf/asia_medical) has announced the addition of the "Asia Medical Technology 100 - An Industry Report" report to their offering. One key trend upcoming in this market is the emergence of user-friendly technologies, which reduce the number of hospital visits and help in the close monitoring of a patient's physiological parameters. The emergence of user-friendly technologies permits the frequent evaluation of these parameters without any assistance from a physician. Asia's medical technology industry is projected to experience top line growth at 2-5 times the rate of developed markets. Global medtech industry is expected to hit US$228 billion by 2015, driven largely by an aging population and climbing societal risk factors such as cardiovascular disease and diabetes. Coupled with longer life expectancy and rising affluence in Asia, this presents companies with immense opportunities to expand the reach of their medical products and business networks in the region. Our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of Asian companies in the medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical technology companies - International presence of Asian medical technology companies - R&D activities by Asian medical technology companies Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Companies Mentioned (Partial List) - A&T Corporation (Japan) - Accuray Medical Equipment (India) Private Limited (India) - Admedus Ltd (Australia) - Analytica Limited (Australia) - Angels Health Private Limited (India) - Ashva Technologies Pvt. Ltd. (India) - Asiamedic Limited (Singapore) - Attune Technologies Private Limited (India) - Axsys Health Tech Limited (India) - Azure Healthcare Ltd (Australia) - Beijing Bohui Innovation Tech (China) - Biodenta Corp (Taiwan) - Bionime Corporation (Taiwan) - Bluechiip Limited (Australia) - Brain Resource Ltd (Australia) - Carefusion Development Private Limited (India) - Cogstate Ltd. (Australia) - Compumedics Limited (Australia) - CoWealth Medical Holding Co., Ltd. (China) - CU Medical Systems Inc (Korea (South)) For more information visit http://www.researchandmarkets.com/research/3b...ia_medical

Leading 100 Global Medical Technology Companies Currently Not Active in India: 2015 An Industry Report
M2 - Mon Mar 09, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2pvzl5/global_medical) has announced the addition of the "Global Medical Technology Not Active in India 100: An Industry Report" report to their offering. The global medical technology industry's market size stands at approximately 350 billion U.S. dollars and is forecasted to grow at 4.4 percent per year to reach $440 billion by 2018. The industry will continue to benefit from emerging market investments that are lifting standards of care, while cost conscious developed markets will continue to invest in more efficient machines, systems and procedures, which offer less hospital time and better patient outcomes. In India, the medical technology industry, the size of which is USD 6.3 billion at present, has the potential to expand to USD 50 billion by 2025 due to its large population, growing middle class, and improving healthcare infrastructure. Further, India, where its forte in software technology is widely-known has initiated steps to involve constructively in the medical technology sector through home-grown innovation as well as through foreign-alliances. With quality R&D skills available locally, India is expected to play a more influential role here. Thus, the global medical technology companies which have not yet set a foot in the Indian medical technology industry need to plan ahead to enter the Indian market. Report Highlights: - Leading global 100 medical technology companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical technology companies not active in India - International presence of global medical technology companies not active in India - R&D activities by global medical technology companies not active in India Companies Mentioned: Partial List of Companies Featured - A&T Corporation (Japan) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - Asiamedic Limited (Singapore) - Azure Healthcare Ltd(Australia) - Bio View Ltd. (Israel) - Bioquell plc(United Kingdom) - Brain Resource Ltd (Australia) - Brainsway Ltd.(Israel) - Cellavision AB (Sweden) - China Resources Wandong Medical Equipment Company Limited (China) - Cogstate Ltd.(Australia) - Cryolife, Inc. (United States) - Cyclopharm Limited(Australia) - Diagnosticos da America S.A.(Brazil) - Digirad Corporation (United States) - DongGuan Eontec Co, Ltd(China) - Draegerwerk AG & Co KGaA (Germany) - Dvx Inc (Japan) - Electrical Geodesics, Inc.(United States) For more information visit http://www.researchandmarkets.com/research/2p...al_medical
ALGN: 91.65 (-0.33)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...